oxazoles has been researched along with Left Ventricular Hypertrophy in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agostinucci, K; Colton, HM; Dunn, ME; Engle, SK; Gallacher, M; Gropp, KE; King, NM; Manfredi, TG; More, V; Powe, J; Rodriguez, LA; Serra, D; Shimpi, P; Vetter, FJ | 1 |
Avanza, AC; Mansur, AP; Ramires, JA | 1 |
Borbás, S; Dienes, BS; Farsang, C; Lengyel, M; Zorándi, A | 1 |
Ayan, F; Ikitimur, B; Koldas, L | 1 |
Bousquet, PP; Monassier, LJ; Signolet, IL | 1 |
DeLuca, N; Lorino, G; Rosiello, G; Rubattu, S; Sarno, D; Trimarco, B; Volpe, M | 1 |
Argenziano, L; De Luca, N; Iovino, G; Morisco, C; Russo, R; Sarno, D; Trimarco, B; Volpe, M | 1 |
Balazovjech, I; Dubai, G; Dvorak, I; Januszewicz, W; Krupa-Wojciechowska, B; Kubasik, A; Kuch-Wocial, A; Polak, G; Sadowski, Z; Simon, K; Stejfa, M; Szwed, H | 1 |
Reid, JL | 1 |
1 review(s) available for oxazoles and Left Ventricular Hypertrophy
Article | Year |
---|---|
Rilmenidine: a clinical overview.
Topics: Albuminuria; Animals; Antihypertensive Agents; Diabetic Angiopathies; Humans; Hyperlipidemias; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Oxazoles; Rilmenidine; Treatment Outcome | 2000 |
4 trial(s) available for oxazoles and Left Ventricular Hypertrophy
Article | Year |
---|---|
Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Enalapril; Exercise Test; Exercise Therapy; Female; Humans; Hypertrophy, Left Ventricular; Losartan; Male; Oxazoles; Renin-Angiotensin System; Rilmenidine; Sympathetic Nervous System | 2009 |
Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients.
Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Echocardiography; Female; Forearm; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Renin; Rilmenidine; Vascular Resistance | 1994 |
Rilmenidine in patients with left ventricular hypertrophy: beyond the reduction of left ventricular mass.
Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Drug Administration Schedule; Electrolytes; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Renin; Rilmenidine | 1995 |
Regression of left ventricular hypertrophy in hypertensive patients after 1 year of treatment with rilmenidine: a double-blind, randomized, controlled (versus nifedipine) study.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diastole; Double-Blind Method; Echocardiography; Electrocardiography, Ambulatory; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine; Oxazoles; Rilmenidine; Treatment Outcome | 1998 |
4 other study(ies) available for oxazoles and Left Ventricular Hypertrophy
Article | Year |
---|---|
Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy.
Topics: Animals; Biomarkers; Cardiotoxicity; Diagnosis, Differential; Hypertrophy, Left Ventricular; Male; Natriuretic Peptides; Oxazoles; PPAR gamma; Rats, Sprague-Dawley; Swimming; Tyrosine; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
Topics: Adrenergic alpha-Agonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Echocardiography; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Perindopril; Rilmenidine | 2003 |
Short-term effects of rilmenidine on left ventricular hypertrophy and systolic and diastolic function in patients with essential hypertension: comparison with an angiotensin converting enzyme inhibitor and a calcium antagonist.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diastole; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Rilmenidine; Systole; Ventricular Function, Left | 2003 |
Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cardiomyopathies; Diastole; Disease Models, Animal; Heart Rate; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Ligation; Male; Metoprolol; Myocardial Contraction; Nephrectomy; Oxazoles; Rabbits; Renal Artery; Rilmenidine; Sympathetic Nervous System; Systole; Time Factors; Ultrasonography; Ventricular Function; Ventricular Remodeling | 2008 |